Mobile app to boost cardiovascular health and exercise motivation during pregnancy
Official title: The Role of Mobile Apps in Promoting Cardiovascular Health and Motivation to Exercise During Pregnancy
Run by Old Dominion University · NCT07166822 · Data updated 2026-11-12
This trial will test whether using the BumptUp mobile exercise app for eight weeks helps healthy pregnant women in their second trimester increase motivation to exercise and improve cardiovascular measures.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 50 (estimated) |
| Sponsor | Old Dominion University Academic / other |
| Locations | 1 site (Norfolk, Virginia) |
| Status | Recruiting |
| Started | September 15, 2025 |
| Main results expected | August 1, 2027 |
| Study ends | August 1, 2028 |
| Registry record updated | September 10, 2025 |
| Trial ID | NCT07166822 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English-speaking, generally healthy pregnant women aged 18-45 with a single pregnancy at 20-24 weeks who are sedentary (under 90 minutes of exercise per week), own a smartphone, and are under routine prenatal care.
✕Probably not a fit
Women with diagnosed cardiovascular or metabolic disease, significant musculoskeletal injury, on medications that affect vascular function, with multiple gestation, or who are already regularly exercising are unlikely to gain benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Healthy, sedentary pregnant women at 20-24 weeks gestation who are 18-45 years old will be assigned to either receive access to the BumptUp exercise app for eight weeks or to a comparison group that does not use the app. Both groups will attend baseline and follow-up lab visits where researchers will measure motivation with questionnaires and objective cardiovascular outcomes including flow-mediated dilation (FMD), heart rate variability (HRV), and pulse wave velocity (PWV). The intervention is delivered via the participant's smartphone and targets increases in habitual physical activity and exercise motivation. Outcomes after the eight-week period will be compared between the app and non-app groups to see if the app produces measurable changes.
Why it matters
Potential benefit: If successful, the app could increase pregnant women's motivation to exercise and produce measurable improvements in vascular health during the second trimester.
How similar studies have gone: Prior mobile-app and prenatal exercise interventions have shown some success increasing activity and motivation, but objective improvements in FMD, HRV, and PWV during pregnancy remain largely untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age: 18-45 years. * Pregnant women who are 20-24 weeks pregnant at enrollment * Sedentary, as defined by completing less than 90 minutes of exercise each week. * Generally healthy, uncomplicated pregnancies. * Free of physical limitations that may interfere with alterations in daily physical activity levels. * Single gestation. * Have a smartphone * Under the routine medical care of an obstetrician or certified nurse midwife during their current pregnancy. * Women speaking English. Exclusion Criteria: * Physician diagnosed cardiovascular/ vascular complications (heart disease, high blood pressure, Raynaud's phenomenon etc.) * Physician diagnosed metabolic diseases (diabetes, hypothyroidism) * Musculoskeletal injuries (broken bones, back pain, ankle sprain, muscle pull, etc.) * Medications that may impact blood vessel function such as hypertension medication (Angiotensin converting enzyme inhibitor, Angiotensin receptor blocker, Calcium channel blocker, beta blocker), lipid lowering agents (statins), Nitrates, steroids, etc. * Complications associated with pregnancy that would be exacerbated by exercise such as lung disease, persistent spotting/bleeding or Placental Previa, premature labor, ruptured membranes, evidence of intrauterine growth restriction, pregnancy induced hypertension or pre-eclampsia, uncontrolled epileptic fits/seizures. * Smoking within the previous 3 months.
Where it's running
-
Old Dominion University
Norfolk, Virginia, United States Recruiting
Study contacts
- Study coordinator: Principal Investigator, PhD
- Email: lreynold@odu.edu
- Phone: 757-683-4974
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Air filters at home to see if breathing cleaner air helps heart health in obesity
This study tests whether portable air filtration systems can improve cardiovascular risk factors in adults with obesity and high blood pressure.
-
Bringing preventive cardiovascular care to Indigenous and remote communities
This project tests a mobile health unit to screen and provide culturally safe cardiovascular and metabolic care for Indigenous and remote communities in Canada.
-
Breast Artery Calcification and Heart Health in Women
This study tests whether a breast artery calcification finding on a mammogram is linked to different cardiovascular markers in women 55–65 who do or do not have BAC.
-
Oxidative Stress and Heart Risk in People with Rheumatoid Arthritis
This study tests whether certain markers of oxidative stress in people with rheumatoid arthritis are linked to subclinical atherosclerosis and arterial stiffness, which could relate to future heart disease risk.
-
Work-Related Frustration and Higher Blood Pressure Risk in Everyday Adults
This observational study tests whether stress and frustration at work relate to blood pressure patterns that signal higher cardiovascular risk among adults aged 40–65 who are working and have no prior cardiovascular disease or blood pressure treatment.
-
Cardiac risk test using breast cancer radiotherapy scans to guide decisions
This study tests whether checking coronary artery calcium on planning CT scans can help patients with breast cancer make informed heart-risk decisions during radiotherapy planning.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.